GNTA peer analysis
Genenta Science (GNTA) against its competitors: price, today's move, 1-year return and market value side by side.
- GNTA's peers: CVM (Cel-Sci), INMB (INmune Bio), IPSC (Century Therapeutics), JUNS (Jupiter Neurosciences), MDCX (Medicus Pharma), SER (Serina Therapeutics), SKYE (Skye Bioscience), TELO (Telomir Pharmaceuticals).
GNTA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CVM Cel-Sci | $1.47 | 6.52% | -76.37% | $25.86M |
| INMB INmune Bio | $0.89 | -13.19% | -40.79% | $27.68M |
| IPSC Century Therapeutics | $1.16 | -12.46% | 123.54% | $209.84M |
| JUNS Jupiter Neurosciences | $1.46 | -3.95% | -98.50% | $1.93M |
| MDCX Medicus Pharma | $1.16 | -16.55% | -98.96% | $1.66M |
| SER Serina Therapeutics | $1.20 | -11.11% | -68.94% | $31.88M |
| SKYE Skye Bioscience | $0.79 | -23.61% | -92.49% | $3.48M |
| TELO Telomir Pharmaceuticals | $0.44 | 4.59% | -69.24% | $32.40M |
| GNTA Genenta Science | $0.98 | 20.62% | -61.52% | – |